| Autor: |
Frommer, W., Archer, L., Boon, B., Brunius, G., Collins, C., Crooy, P., Doblhoff-Dier, O., Donikian, R., Economidis, J., Frontali, C., Gaal, T., Hamp, S., Haymerle, H., Houwink, E., Küenzi, M., Krämer, P., Lelieveld, H., Logtenberg, M., Lupker, J., Lund, S. |
| Zdroj: |
Applied Microbiology & Biotechnology; 1993, Vol. 39 Issue 2, p141-147, 7p |
| Abstrakt: |
The benefits of using animal or human cell cultures have been clearly demonstrated in diagnostic and therapeutic research and in their application for manufacturing. Cell cultures serve as a tools for the production of vaccines, receptors, enzymes, monoclonal antibodies and recombinant DNA-derived proteins. They represent an integral part of drug development for which corresponding facilities, equipment and manufacturing processes are required. Although the cells themselves offer no particular risk to workers in laboratories and production areas or to the environment, the cell cultures may be contaminated with viruses, mycoplasma, bacteria, yeast and fungi or might contain endogenous viruses. The containment level for animal and human cells is therefore determined by the risk class of these agents. The history of animal and human cell cultures has proved that they can be handled safely. The recommendations in this publication concern the safe handling of cell cultures (tissue explants, primary cell cultures) and permanent cell lines of animal and human origin. A classification system of safety precautions has been elaborated according to the potential for contamination with the pathogenic agents involved. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink